UniQure, Lexington, MA

  • New facility provides 15,000sf of virus-based gene therapy manufacturing space supported by 37,000 sf of clean laboratory and office space that will be used to provide their single potentially curative treatments for patients with orphan metabolic and ocular diseases.
  • Cutting-edge facility incorporates a complete production suite from media development through filling/packaging. It is designed to support both open and closed processes, has the capability to run at least two separate batches or products simultaneously, and is in compliance with cGMP, EMEA, and J-GMP requirements.
  • Support areas include complete process development, microbiology, and quality control laboratories, environmental rooms, and all process utilities.
  • The uniQure / Richmond team was able to collaboratively plan, design, and build this innovative facility from concept to completion in an extremely aggressive 10 months, while successfully meeting all project budgetary goals.